Cargando…

Kallistatin exerts anti-lymphangiogenic effects by inhibiting lymphatic endothelial cell proliferation, migration and tube formation

Kallistatin has been recognized as an endogenous angiogenic inhibitor. However, its effects on lymphatic endothelial cells and lymphangiogenesis remain poorly understood. Lymphangiogenesis is involved in tumor metastasis via the lymphatic vasculature in various types of tumors. The aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Caiqi, Yin, Haofan, Zhong, Jun, Zhang, Yang, Luo, Chuanghua, Che, Di, Fang, Zhenzhen, Li, Lei, Qin, Shuxing, Liang, Jieying, Qi, Weiwei, Yang, Zhonghan, Zhou, Ti, Ma, Jianxing, Yang, Xia, Gao, Guoquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435323/ https://www.ncbi.nlm.nih.gov/pubmed/28440474 http://dx.doi.org/10.3892/ijo.2017.3972

Ejemplares similares

OxLDL promotes lymphangiogenesis and lymphatic metastasis in gastric cancer by upregulating VEGF-C expression and secretion
por: Ma, Caiqi, et al.
Publicado: (2018)

PEDF inhibits lymphatic metastasis of nasopharyngeal carcinoma as a new lymphangiogenesis inhibitor
por: Luo, Chuanghua, et al.
Publicado: (2021)

Manganese superoxide dismutase mediates anoikis resistance and tumor metastasis in nasopharyngeal carcinoma
por: Li, Shuai, et al.
Publicado: (2016)

Mesenchymal marker expression is elevated in Müller cells exposed to high glucose and in animal models of diabetic retinopathy
por: Zhou, Ti, et al.
Publicado: (2016)

Mesenchymal stem cells promote lymphangiogenic properties of lymphatic endothelial cells
por: Robering, Jan W., et al.
Publicado: (2018)

Kallistatin Deficiency Induces the Oxidative Stress-Related Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells: A Novel Protagonist in Age-Related Macular Degeneration
por: Shen, Gang, et al.
Publicado: (2023)

β2-adrenergic receptor signaling promotes neuroblastoma cell proliferation by activating autophagy
por: Deng, Jing, et al.
Publicado: (2019)

TIE-2-expressing monocytes are lymphangiogenic and associate specifically with lymphatics of human breast cancer
por: Bron, Sylvian, et al.
Publicado: (2015)

FUBP1 promotes colorectal cancer stemness and metastasis via DVL1‐mediated activation of Wnt/β‐catenin signaling
por: Yin, Haofan, et al.
Publicado: (2021)

Reduced Plasma Kallistatin Is Associated With the Severity of Coronary Artery Disease, and Kallistatin Treatment Attenuates Atherosclerotic Plaque Formation in Mice
por: Yao, Yuyu, et al.
Publicado: (2018)

Kallistatin - the score beats the marker
por: Draikiwicz, Steven, et al.
Publicado: (2013)

Crystallization and crystallographic studies of kallistatin
por: Lin, Fang, et al.
Publicado: (2015)

FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma
por: Jiang, Ping, et al.
Publicado: (2019)

Kallistatin limits abdominal aortic aneurysm by attenuating generation of reactive oxygen species and apoptosis
por: Krishna, Smriti Murali, et al.
Publicado: (2021)

Adipose triglyceride lipase promotes the proliferation of colorectal cancer cells via enhancing the lipolytic pathway
por: Yin, Haofan, et al.
Publicado: (2021)

Pigment epithelium‐derived factor/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol
por: Zhu, Liuqing, et al.
Publicado: (2018)

Metformin selectively inhibits metastatic colorectal cancer with the KRAS mutation by intracellular accumulation through silencing MATE1
por: Xie, Jinye, et al.
Publicado: (2020)

Kallistatin Attenuates Experimental Autoimmune Uveitis by Inhibiting Activation of T Cells
por: Muhammad, Fauziyya, et al.
Publicado: (2020)

Diabetes‐induced upregulation of kallistatin levels exacerbates diabetic nephropathy via RAS activation
por: Yang, Yanhui, et al.
Publicado: (2020)

Elevated Kallikrein-binding protein in diabetes impairs wound healing through inducing macrophage M1 polarization
por: Feng, Juan, et al.
Publicado: (2019)

Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin
por: Shiau, Ai-Li, et al.
Publicado: (2010)

KSHV Induction of Angiogenic and Lymphangiogenic Phenotypes
por: DiMaio, Terri A., et al.
Publicado: (2012)

Inhibition of integrin β3, a binding partner of kallistatin, leads to reduced viability, invasion and proliferation in NCI-H446 cells
por: Wang, Guoquan, et al.
Publicado: (2016)

Metabolomics revealed the influence of breast cancer on lymphatic endothelial cell metabolism, metabolic crosstalk, and lymphangiogenic signaling in co-culture
por: Acevedo-Acevedo, Suehelay, et al.
Publicado: (2020)

Opposing Effects of Oxygen Regulation on Kallistatin Expression: Kallistatin as a Novel Mediator of Oxygen-Induced HIF-1-eNOS-NO Pathway
por: Chao, Julie, et al.
Publicado: (2017)

Antiangiogenic and Antineuroinflammatory Effects of Kallistatin Through Interactions With the Canonical Wnt Pathway
por: Liu, Xiaochen, et al.
Publicado: (2013)

The contrary intracellular and extracellular functions of PEDF in HCC development
por: Li, Cen, et al.
Publicado: (2019)

Identification of Gene Expression Differences between Lymphangiogenic and Non-Lymphangiogenic Non-Small Cell Lung Cancer Cell Lines
por: Regan, Erin, et al.
Publicado: (2016)

The Potential Role of Kallistatin in the Development of Abdominal Aortic Aneurysm
por: Li, Jiaze, et al.
Publicado: (2016)

Lymphangiogenic factors are associated with the severity of hypersensitivity pneumonitis
por: Yamashita, Masahiro, et al.
Publicado: (2015)

Tumor Lymphatic Interactions Induce CXCR2-CXCL5 Axis and Alter Cellular Metabolism and Lymphangiogenic Pathways to Promote Cholangiocarcinoma
por: Roy, Sukanya, et al.
Publicado: (2021)

Heparin Blocks the Inhibition of Tissue Kallikrein 1 by Kallistatin through Electrostatic Repulsion
por: Ma, Lina, et al.
Publicado: (2020)

Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis
por: Li, Pengfei, et al.
Publicado: (2015)

Increased serum kallistatin levels in type 1 diabetes patients with vascular complications
por: Jenkins, Alicia J, et al.
Publicado: (2010)

Plasma kallistatin levels in patients with severe community-acquired pneumonia
por: Lin, Wei-Chieh, et al.
Publicado: (2013)

Kallistatin, a new and reliable biomarker for the diagnosis of liver cirrhosis
por: Cheng, Zhiyun, et al.
Publicado: (2015)

Kallistatin prevents ovarian hyperstimulation syndrome by regulating vascular leakage
por: Huang, Jianfang, et al.
Publicado: (2022)

Inflammation and Progression of Cholangiocarcinoma: Role of Angiogenic and Lymphangiogenic Mechanisms
por: Roy, Sukanya, et al.
Publicado: (2019)

Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
por: Wu, Huan, et al.
Publicado: (2019)

Overexpressing Kallistatin Aggravates Experimental Autoimmune Uveitis Through Promoting Th17 Differentiation
por: Chen, Nu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_31mdbc7f6r4vkj34i8jqj7f12d